121 related articles for article (PubMed ID: 512520)
21. Fatal paracetamol poisoning from benorylate therapy in child with cystic fibrosis.
Symon DN; Gray ES; Hanmer OJ; Russell G
Lancet; 1982 Nov; 2(8308):1153-4. PubMed ID: 6128464
[No Abstract] [Full Text] [Related]
22. Letter: Salicylate hepatotoxicity and HL-A-W27.
Schulman P
Ann Intern Med; 1976 Jun; 84(6):754-5. PubMed ID: 937899
[No Abstract] [Full Text] [Related]
23. Dosage of salicylates for children with juvenile rheumatoid arthritis. A preliminary report.
Mäkelä AL; Tryänä T; Haapasaari J
Scand J Rheumatol; 1975; 4(4):250-2. PubMed ID: 1198081
[TBL] [Abstract][Full Text] [Related]
24. Hepatic, cutaneous and hematologic manifestations in juvenile chronic arthritis.
Barash J; Cooper M; Tauber Z
Clin Exp Rheumatol; 1991; 9(5):541-3. PubMed ID: 1954707
[TBL] [Abstract][Full Text] [Related]
25. Salicylate-induced hepatitis in rheumatic fever.
Hamdan JA; Manasra K; Ahmed M
Am J Dis Child; 1985 May; 139(5):453-5. PubMed ID: 3984967
[TBL] [Abstract][Full Text] [Related]
26. Digital artery thrombosis and vasculitis in juvenile rheumatoid arthritis.
Carson RA
Can Med Assoc J; 1973 Sep; 109(5):384-6. PubMed ID: 4742476
[TBL] [Abstract][Full Text] [Related]
27. Synovial cysts in juvenile rheumatoid arthritis.
Bamzai A; Krieger M; Kretschmer RR
Ann Rheum Dis; 1978 Feb; 37(1):101-3. PubMed ID: 629596
[TBL] [Abstract][Full Text] [Related]
28. Children with juvenile rheumatoid arthritis treated with salicylates for 15 days, with daily serum salicylate determinations.
Calabro JJ; Brunstein SL; Staley HL
Scand J Rheumatol; 1976; 5(4):251-2. PubMed ID: 1006215
[No Abstract] [Full Text] [Related]
29. Pharmacokinetic monitoring of salicylate therapy in children with juvenile rheumatoid arthritis.
Pachman LM; Olufs R; Procknal JA; Levy G
Arthritis Rheum; 1979 Aug; 22(8):826-31. PubMed ID: 465097
[TBL] [Abstract][Full Text] [Related]
30. Toxic encephalopathy with hyperammonaemia during high-dose salicylate therapy.
Mäkelä AL; Lang H; Korpela P
Acta Neurol Scand; 1980 Mar; 61(3):146-56. PubMed ID: 7395459
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of liver disease in patients taking salicylates for arthropathy.
Carneskog J; Florath-Ahlmen M; Olsson R
Hepatogastroenterology; 1980 Oct; 27(5):361-4. PubMed ID: 7203370
[TBL] [Abstract][Full Text] [Related]
32. Chronic salicylism in a patient with juvenile rheumatoid arthritis.
Everson GW; Krenzelok EP
Clin Pharm; 1986 Apr; 5(4):334-41. PubMed ID: 3709082
[TBL] [Abstract][Full Text] [Related]
33. Salicylate hepatotoxicity: the potential role of hypoalbuminemia.
Gitlin N
J Clin Gastroenterol; 1980 Sep; 2(3):281-5. PubMed ID: 7451927
[TBL] [Abstract][Full Text] [Related]
34. Hepatotoxicity associated with choline magnesium trisalicylate: case report and review of salicylate-induced hepatotoxicity.
Cersosimo RJ; Matthews SJ
Drug Intell Clin Pharm; 1987; 21(7-8):621-5. PubMed ID: 3301251
[TBL] [Abstract][Full Text] [Related]
35. Aspirin hepatitis.
Zucker P; Daum F; Cohen MI
Am J Dis Child; 1975 Dec; 129(12):1433-4. PubMed ID: 1199984
[TBL] [Abstract][Full Text] [Related]
36. Compliance with salicylate therapy in adolescents with juvenile rheumatoid arthritis.
Litt IF; Cuskey WR
Am J Dis Child; 1981 May; 135(5):434-6. PubMed ID: 7234770
[TBL] [Abstract][Full Text] [Related]
37. [Liver damage following salicylate intake].
Bar-Meir S; Papa MZ
Harefuah; 1975 Mar; 88(5):241. PubMed ID: 1132819
[No Abstract] [Full Text] [Related]
38. Salicylate therapy in juvenile rheumatoid arthritis. Dose, serum level, and toxicity.
Doughty RA; Giesecke L; Athreya B
Am J Dis Child; 1980 May; 134(5):461-3. PubMed ID: 7377152
[TBL] [Abstract][Full Text] [Related]
39. Aspirin, liver, and rheumatic diseases.
Halla JT
J Med Assoc State Ala; 1976 Sep; 46(3):23-5. PubMed ID: 789798
[No Abstract] [Full Text] [Related]
40. Letter: The liver and arthritis.
Goldsmith DP; Tourtelotte CD
Am J Dis Child; 1976 Sep; 130(9):1035. PubMed ID: 961651
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
